These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27538750)

  • 1. cDNA-library testing identifies transforming genes cooperating with c-myc in mouse pre-B cells.
    Wolf I; Bouquet C; Melchers F
    Eur J Immunol; 2016 Nov; 46(11):2555-2565. PubMed ID: 27538750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
    Bouquet C; Melchers F
    Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing pre-BI cells.
    Wolf I; Bouquet C; Naumann F; Melchers F
    Eur J Immunol; 2017 May; 47(5):911-920. PubMed ID: 28294314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model.
    Jang SH; Lee S; Chung HY
    PLoS One; 2015; 10(11):e0143240. PubMed ID: 26606454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
    Högstrand K; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
    Nakagawa M; Tsuzuki S; Honma K; Taguchi O; Seto M
    Haematologica; 2011 Sep; 96(9):1318-26. PubMed ID: 21606168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
    Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
    Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
    Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
    Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of mature mouse B cells into malignant plasma cells in vitro via introduction of defined genetic elements.
    Högstrand K; Lindvall JM; Sundblad A; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):454-461. PubMed ID: 30664244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
    Smith DP; Bath ML; Harris AW; Cory S
    Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth.
    Bossen C; Murre CS; Chang AN; Mansson R; Rodewald HR; Murre C
    Nat Immunol; 2015 Jul; 16(7):775-84. PubMed ID: 25985234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells.
    Wang P; Lushnikova T; Odvody J; Greiner TC; Jones SN; Eischen CM
    Oncogene; 2008 Mar; 27(11):1590-8. PubMed ID: 17828300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma.
    Wong DM; Li L; Jurado S; King A; Bamford R; Wall M; Walia MK; Kelly GL; Walkley CR; Tarlinton DM; Strasser A; Heierhorst J
    Cell Rep; 2016 Feb; 14(6):1488-1499. PubMed ID: 26832406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible lymphomagenesis in conditionally c-MYC expressing mice.
    Marinkovic D; Marinkovic T; Mahr B; Hess J; Wirth T
    Int J Cancer; 2004 Jun; 110(3):336-42. PubMed ID: 15095297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.